Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors - van Eggermond, Anna M; Schaapveld, Michael; Janus, Cécile PM; de Boer, Jan Paul; Krol, Augustinus DG; Zijlstra, Josée M; van der Maazen, Richard WM; Kremer, Leontien C; van Leerdam, Monique E; Louwman, Marieke WJ; Visser, Otto; De Bruin, Marie L; et al. (British journal of cancer, 2017)
Keywords: 692/4028/67/1059/485; 692/4028/67/1504/1885; 692/4028/67/1990/291/1556; 692/499; Adult; Antineoplastic Agents - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biomedical and Life Sciences; Biomedicine; Bleomycin - therapeutic use; Cancer Research; Cancer therapies; Chemotherapy; Clinical Study; Colon; Colon cancer; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - epidemiology; Colorectal Neoplasms - etiology; Diaphragm; Doxorubicin - therapeutic use; Drug Resistance; Epidemiology; Female; Follow-Up Studies; Hodgkin Disease - drug therapy; Hodgkin Disease - radiotherapy; Hodgkin's lymphoma; Humans; Lymphoma; Male; Mechlorethamine - therapeutic use; Middle Aged; Molecular Medicine; Neoplasms, Radiation-Induced - epidemiology; Neoplasms, Radiation-Induced - etiology; Neoplasms, Second Primary - epidemiology; Neoplasms, Second Primary - etiology; Netherlands - epidemiology; Oncology; Prednisone - therapeutic use; Procarbazine; Procarbazine - administration & dosage; Procarbazine - therapeutic use; Radiation therapy; Rectum; Risk Factors; Survivors; Vinblastine - therapeutic use; Vincristine - therapeutic use; Young Adult; colorectal cancer; radiation therapy; chemotherapy; procarbazine; second malignant neoplasm; long-term complications; Hodgkin lymphoma